Cerus Corp (NASDAQ:CERS)

4.10
Delayed Data
As of Mar 27
 -0.11 / -2.61%
Today’s Change
3.48
Today|||52-Week Range
7.03
-34.29%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$390.2M

Company Description

Cerus Corp. is a biomedical products company, which is engaged in developing and commercializing the INTERCEPT blood system. It currently markets and sells the INTERCEPT blood system for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Contact Information

Cerus Corp.
2550 Stanwell Drive
Concord California 94520
P:(925) 288-6000
Investor Relations:
(925) 288-6319

Employees

Shareholders

Individual stakeholders5.19%
Other institutional44.75%
Mutual fund holders19.34%

Top Executives

William Mariner GreenmanPresident, Chief Executive Officer & Director
Suzanne MargerumVice President-Manufacturing & Operations
Kevin Dennis GreenChief Financial Officer & Vice President
Laurence M. CorashDirector, SVP, Chief Scientific & Medical Officer
Adonis StassinopoulosVP-Global Scientific Affairs & Research

To view my watchlist

Not a member yet?

Sign up now for a free account